The Uro-GHD features a 1280x720 pixel sensor, a first in portable, single-use endoscopy. LOS ALTOS, CA / ACCESSWIRE / April 7, 2023 / UroViu Corp (www.uroviu.com) has launched the new Uro-GHD, a ...

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...

UroViu Corporation, a company develops a suite of diagnostic and therapeutic endoscopic products, has announced that its Uro-V single-use diagnostic cystoscopic system has received 510(k) clearance ...

A cystoscopy is a test to check the health of your urethra and bladder. You might also hear it called a cystourethroscopy or, more simply, a bladder scope. It’s an outpatient test, which means you can ...

LOS ALTOS, Calif.--(BUSINESS WIRE)--UroViu Corporation announced today that it has received CE certification for its cystoscope and hysteroscope product portfolio. This includes the reusable UV5000w ...

SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of ...

Bladder biopsy of normal-looking mucosa, as determined by cystoscopy, might not add clinical value in patients with positive voided-urine cytology after treatment of non-muscle-invasive bladder cancer ...

ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy ...

These differences remained significant beyond the initial 90 days, indicating durable diagnostic sensitivity and facilitating earlier, risk-appropriate treatment decisions, which supports broader ...

SHANGHAI, Feb. 21, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of ...